Role of transforming growth factor Beta in human cancer.
about
Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumorsEvaluation of protein biomarkers of prostate cancer aggressivenessMulti-walled carbon nanotube-induced gene expression in the mouse lung: association with lung pathologyMultiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosisCasein kinase 2beta as a novel enhancer of activin-like receptor-1 signalingOverexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesisPrognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancerCloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissuesMolecular profiling of cervical cancer progressionProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsThe Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal MetastasisGenetic instability in the tumor microenvironment: a new look at an old neighborAssociation between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studiesTGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapyCrosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancerPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Posttranscriptional regulation of cancer traits by HuRTGF-beta: a mobile purveyor of immune privilegeFrom Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical ResearchModulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motilityTGF-β signaling in T cells: roles in lymphoid and epithelial neoplasiaTransforming growth factor beta controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin.The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transitionGenetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.Genetic variation in bone morphogenetic protein and colon and rectal cancer.In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 proteinExpression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.Tumour vascularization: sprouting angiogenesis and beyondSmad4-mediated TGF-beta signaling in tumorigenesis.SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancerTransforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signalingType III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathwayIntegrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts.The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathwayAssociations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.Roles for the type III TGF-beta receptor in human cancer
P2860
Q21134548-48AA55EE-5881-4177-9D48-820FCD41BE21Q21261257-107B8D4D-D315-431B-841B-152931700D98Q23917421-C55D409B-DBDF-433B-8673-85D663A3D0FBQ23918758-4D4CD1A5-3C86-4A15-8E8E-990B5474CC44Q24313348-C5722BA8-0D65-437C-A24F-DFC20959B896Q24317766-9700DFE3-2C35-40B5-9CD5-30C87736E22FQ24337061-431ECA35-324D-4962-8D16-385B3E2C8F37Q24337448-654058B9-DCA6-4360-A16E-54B1215167C9Q24653706-F4263607-CC5C-4C66-8D6E-6D4B7013A8E7Q26773613-B58FF6D9-1BB3-43EC-8AB8-ECABDBB4D9E2Q26783022-FC8A8B98-8778-4C1A-A7DC-0DF7D8BAF76FQ26801374-48BC2CC7-CBDD-4CD5-8B65-760A7E9B0B2AQ26849553-7663E290-48B4-4919-9456-2C3D643DA1A3Q26862838-11D6F0AA-9FD2-48E5-B404-1A29AB8BA262Q28084851-8D399196-FAD4-44E3-BDA6-1EDC47BFA757Q28209990-89BFEED3-519D-4AB0-A878-9654246DF77CQ28248667-75A836BC-BF26-4AAF-BE9F-0F4D157A14A0Q28263622-9F5E4D89-4D38-41A2-B829-3A85FB5D518EQ28393309-10089F83-BBB6-4319-A370-8B01A1594635Q28594979-CAFB90BE-B2D9-4AD0-AE38-984C092915FEQ29036999-1242D6FB-0BCE-41D2-A5E8-5BB260787A8DQ30481397-C0A072CC-78AD-466D-A94B-DBF43FC4ACACQ30487886-464C2E59-101B-42E0-93A3-F7539D485093Q30498249-2E663F34-AF45-46ED-96C6-7B5DA5C73951Q30498922-28A8CA5D-DCF5-40AC-966E-7EB1894FEDD4Q30503444-D0E771AA-B0CE-4444-B975-6E6CFB363979Q30936571-68539AF9-083F-415E-9F51-0581202975D9Q33320906-062B590A-8FBC-467B-B2F4-9F32057CD742Q33495718-2BB051B7-C4EE-4F83-946F-4C76AC5E697AQ33556162-CE847C19-0B10-4322-8BB1-BE9C1E1659EEQ33596982-25A6B9F9-BA2A-4BF6-84A3-79A9B3CD9F1DQ33610904-44EFCBCC-926A-4522-95D0-EE5742285E9CQ33699084-E91736C4-2D5C-42E8-A065-60BD3E5C94BAQ33728145-CB11ADEE-6686-4A3F-9EF9-74C7FC6BC417Q33749558-B1B40C2B-90AB-47D6-927C-DF221702ACE4Q33812463-8C4CF935-BF08-4ECB-862E-44AE59F6370FQ33830232-967DE0A5-558E-409B-990B-FD680FA091E3Q33833162-F9174D95-3C39-40DB-964F-20B9E5861FAEQ33869600-21AFF6EF-5B7B-4E0F-99AF-B6B11527E7CAQ33872593-9F03C59A-D81F-4966-8685-888D9F14FF1C
P2860
Role of transforming growth factor Beta in human cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of transforming growth factor Beta in human cancer.
@ast
Role of transforming growth factor Beta in human cancer.
@en
type
label
Role of transforming growth factor Beta in human cancer.
@ast
Role of transforming growth factor Beta in human cancer.
@en
prefLabel
Role of transforming growth factor Beta in human cancer.
@ast
Role of transforming growth factor Beta in human cancer.
@en
P356
P1476
Role of transforming growth factor Beta in human cancer.
@en
P2093
Gerard C Blobe
Rebecca L Elliott
P304
P356
10.1200/JCO.2005.02.047
P407
P577
2005-03-01T00:00:00Z